Evidence map›Paper›PMID 41134139›Full record

ArticleRadiology. Imaging cancer2025

MRI-based Intra- and Peritumoral Heterogeneity in Hepatocellular Carcinoma for Microvascular Invasion Prediction and Prognostic Risk Stratification.

Yunfei Zhang, Shutong Wang, Mingyue Song, Ruofan Sheng, Zhijun Geng, Weiguo Zhang, Mengsu Zeng

Abstract read
In one paragraph

Article in Radiology. Imaging cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yunfei Zhang *Department of Radiology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.
Shutong Wang *Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Mingyue SongDepartment of Radiology, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou, China.
Ruofan ShengDepartment of Radiology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.
Zhijun GengDepartment of Radiology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in Southern China, Guangzhou, China.
Weiguo Zhang *Department of Radiology, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou, China.
Mengsu Zeng *Department of Radiology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.ORCID 0000-0002-7342-0159

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To evaluate an MRI-based strategy for quantifying intra- and peritumoral heterogeneity (ITH and PTH) in hepatocellular carcinoma (HCC) and develop ITH- and PTH-based models for diagnosing microvascular invasion (MVI) and stratifying prognostic risk. Materials and Methods Patients with HCC (≤5 cm) were retrospectively included from three different institutions from March 2012 to September 2023 and divided into internal training, internal testing, and external testing cohorts. Tumor and peritumoral tissues in MR images were categorized into distinct habitats using unsupervised clustering algorithms. High-throughput radiomic features were extracted from each habitat. The degree of feature variation within each habitat was quantified to derive characteristics representing ITH and PTH. Engineered features were developed to train machine learning models for MVI diagnosis. Kaplan-Meier survival curves and Cox regression analysis were used for survival analysis. Results A total of 432 patients (mean age, 54.31 years ± 11.15 [SD]; 371 male) were included. The TH_DNN model, constructed using ITH- and PTH-based quantitative features combined with a deep neural network (DNN), demonstrated the best predictive performance for MVI across the three datasets (area under the receiver operating characteristic curve range = 0.82-0.99). The subgroup predicted as MVI positive with the TH_DNN model exhibited a poorer prognosis than the MVI-negative subgroup. In terms of overall survival and postoperative recurrence, the hazard ratios for MVI diagnosis were 2.79 (95% CI: 1.35, 5.75;

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMagnetic Resonance ImagingMicrovesselsAdultAgedFemaleHumansMaleMiddle AgedNeoplasm InvasivenessPrognosisRetrospective StudiesRisk AssessmentHepatocellular CarcinomaIntratumoral HeterogeneityLiverMicrovascular InvasionMRIOncologyPeritumoral HeterogeneityTumor habitat

Identifiers

PMID41134139
PMCPMC12670032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.